Research Articles | Page 85 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A retrospective study of paroxysmal nocturnal hemoglobinuria in pediatric and adolescent patients Mar 2017 Blood Cells Mol Dis paroxysmal nocturnal hemoglobinuria (PNH)
The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes Mar 2015 Blood Cancer J myelodysplastic syndromes (MDS)
Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes Sep 2017 Blood Cancer J myelodysplastic syndromes (MDS)
Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation Mar 2012 Blood Cancer J paroxysmal nocturnal hemoglobinuria (PNH)
Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients Mar 2017 Blood Cancer J myelodysplastic syndromes (MDS)
Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes. Feb 2017 Blood Cancer J myelodysplastic syndromes (MDS)
Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes. Feb 2017 Blood Cancer J myelodysplastic syndromes (MDS)
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome Apr 2023 Blood Cancer myelodysplastic syndromes (MDS)
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS Jul 2023 Blood Advances myelodysplastic syndromes (MDS)
Risk and timing of cardiovascular death among patients with myelodysplastic syndromes Oct 2017 Blood Advances myelodysplastic syndromes (MDS)
Share with addtoany.com.